Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
Overview
Diabetes Therapy is a comprehensive journal dedicated to advancing knowledge in the field of diabetes and related disorders. It focuses on research, treatment, and education, providing a platform for scientists, clinicians, and educators to share their findings and insights. With a multidisciplinary approach, this journal aims to improve the understanding, management, and prevention of diabetes, ultimately enhancing the quality of life for individuals affected by this chronic condition.
Details
Details
Abbr.
Diabetes Ther
Start
2010
End
Continuing
p-ISSN
1869-6953
e-ISSN
1869-6961
Country
United States
Language
English
Specialty
Cardiology & Vascular Diseases
Metrics
Metrics
h-index / Ranks: 7077
52
SJR / Ranks: 4232
938
CiteScore / Ranks: 3827
6.00
JIF / Ranks: 2461
3.8
Recent Articles
21.
Ding S, Sun J, Wang L, Wu L, Liu W
Diabetes Ther
. 2025 Feb;
16(3):499-511.
PMID: 39928222
Introduction: Diabetic kidney disease (DKD) represents a significant microvascular complication associated with diabetes and serves as a major contributor to end-stage renal disease. While many studies have highlighted the renal...
22.
Aranishi T, Igarashi A, Hara K, Osumili B, Cai Z, Mizogaki A, et al.
Diabetes Ther
. 2025 Feb;
16(3):447.
PMID: 39918684
No abstract available.
23.
Kessler L, Thivolet C, Penfornis A, Gouet D, Coffin C, Moret M, et al.
Diabetes Ther
. 2025 Feb;
16(3):429-430.
PMID: 39913053
No abstract available.
24.
Wang H, Zu Q, Lu M, Chen R, Tang Z, Yang Z
Diabetes Ther
. 2025 Jan;
16(3):485-498.
PMID: 39883288
Introduction: Scientific publications have shown sodium-glucose co-transporter-2 (SGLT2) inhibitors to have several beneficial effects in patients with complex type 2 diabetes mellitus (T2DM). However, sodium-glucose co-transporter-1 (SGLT-1) inhibitor is still...
25.
Penfornis A, Down S, Seignez A, Vives A, Bonnemaire M, Kulzer B
Diabetes Ther
. 2025 Jan;
16(3):471-484.
PMID: 39883287
Introduction: Type 1 diabetes (T1D) requires constant self-management and substantially impacts daily life. We surveyed the experiences/burdens of people with T1D (PWD) and their caregivers. Methods: An online survey of...
26.
James S, Saiyed M, James O, Gokalani R, Paterson M, Mehta K, et al.
Diabetes Ther
. 2025 Jan;
16(3):329-348.
PMID: 39799521
Introduction: Young adulthood is well documented as being a particularly challenging area of type 1 diabetes (T1D) healthcare. Many young adults with T1D (YAT1D) are distracted from effective disease self-management;...
27.
Wang T, Cui Y, Liao L
Diabetes Ther
. 2025 Jan;
16(3):449-470.
PMID: 39797937
Introduction: More than half of diabetes patients are Asians, and their tolerance to antidiabetic drugs may differ from that of non-Asians. Oral semaglutide has recently gained attention for its advantages...
28.
Mody R, Desai K, Teng C, Reznor G, Stockbower G, Grabner M, et al.
Diabetes Ther
. 2025 Jan;
16(2):307-327.
PMID: 39794609
Introduction: The study objective was to describe characteristics and utilization patterns of tirzepatide users with type 2 diabetes (T2D) using the Healthcare Integrated Research Database in the USA. Methods: Adults...
29.
Greenfield J, Frampton R, Millard K, Snaith J
Diabetes Ther
. 2025 Jan;
16(2):145-148.
PMID: 39760824
Type 1 diabetes is associated with excess cardiovascular risk, even after accounting for traditional cardiovascular risk factors, including glycaemia. Hence, there is an urgent need to document the metabolic abnormalities...
30.
Rich J, Ferguson-Davis H
Diabetes Ther
. 2024 Dec;
16(2):137-144.
PMID: 39731698
Type 2 diabetes (T2D) frequently coexists with cardiorenal complications. Therefore, a holistic approach to patient management is required, with specialists such as primary care physicians, cardiologists, endocrinologists, and nephrologists working...